BILL ANALYSIS                                                                                                                                                                                                    




           AB 2077
                                                                  Page  1

          CONCURRENCE IN SENATE AMENDMENTS
          AB 2077 (Solorio)
          As Amended  August 20, 2010
          Majority vote
           
           ----------------------------------------------------------------- 
          |ASSEMBLY:  |68-5 |(May 13, 2010)  |SENATE: |35-0 |(August 24,    |
          |           |     |                |        |     |2010)          |
           ----------------------------------------------------------------- 
            
           Original Committee Reference:    B.,P. & C.P.  

           SUMMARY  :   Permits a hospital pharmacy to compound or repackage  
          drugs for other hospitals and pharmacies under common ownership.  
           

           The Senate amendments  :

          1)Require any unit-dose medication produced by a hospital  
            pharmacy under common ownership, as specified, to be bar-coded  
            and readable at the patient's bedside.

          2)Permit a hospital pharmacy to prepare and store a limited  
            quantity of unit-dose medications in advance of receipt of a  
            patient-specific prescription in a quantity as is necessary to  
            ensure continuity of care for an identified population of  
            patients of the hospital based on a documented history of  
            prescriptions for that patient population.

          3)Require a hospital pharmacy, hospital, or pharmacist to comply  
            with all applicable federal and state laws.

          4)Require a pharmacy compounding or repackaging a drug to notify  
            the Board of Pharmacy (BOP) in writing of the location where  
            the compounding or repackaging is being performed within 30  
            days of initiating the compounding or repackaging. The  
            pharmacy shall report any change in that information to the  
            board in writing within 30 days of the change.

          5)Specify that a hospital pharmacy that is not on the same  
            premises be located within a 100 mile radius of the hospital  
            regulated under a hospital's license.

           EXISTING LAW  :









           AB 2077
                                                                  Page  2


          1)Provides for the licensure and regulation of pharmacies,  
            including hospital pharmacies, by the BOP. 

          2)Prohibits the operation of a pharmacy without a license, and  
            requires a separate license for each pharmacy location. 

          3)Restricts a hospital pharmacy to providing pharmaceutical  
            services to registered hospital patients on the premises of  
            the same physical plant in which the pharmacy is located. 

          4)Provides that a knowing violation of the Pharmacy Law is a  
            crime.

           AS PASSED BY THE ASSEMBLY  , this bill was substantially similar  
          to the version approved by the Senate.

           FISCAL EFFECT  :  According to the Senate Appropriations Committee  
          analysis:


                            Fiscal Impact (in thousands)

           Major Provisions         2010-11      2011-12       2012-13     Fund
           Hospital pharmacy      Up to $455*Up to $837  Up to  
          $837Special**
          inspections            Minor, absorbable costs***        
          Special****                                   
          * Department of Public Health estimate
          **Department of Public Health Licensing & Certification Program  
          Fund (4265-3098)
          ***Board of Pharmacy estimate
          ****Pharmacy Board Contingent Fund
           

          Analysis Prepared by  :    Sarah Weaver / B.,P. & C.P. / (916)  
          319-3301 


                                                               FN: 0006675